The ExPERT GTx electroporator is capable of high-performance delivery of virtually any molecule, into any cell, at different scales with the unique ability to transfect primary cells, stem cells and cell lines with minimal disturbance resulting in transfection efficiencies routinely at or above 90 percent.
The GTx stands out as the sole enabler of a commercially available, non-viral manufactured advanced therapy medicinal product (ATMP). It showcases the industry’s foremost clinically-validated and scalable electroporation technology, specifically designed for complex cellular engineering.
From product development to translation into clinical trials, GTx’s clinically validated scalable electroporation technology is equipped to handle your most complex cellular engineering demands.
- Rapidly transfect from 75 thousand to 20 billion cells.
- Move forward with 21 CFR Part 11 enabled software.
- Develop quickly with an established regulatory path supported by a FDA Master File.
- Manufacture confidently with closed, cGMP-compliant, ISO-certified and CE-marked products.
- Enjoy MaxCyte’s proprietary Flow ElectroporationⓇ technology.